Abstract
Dendritic cells (DC) as potent antigen-presenting cells (APC) and T cells as effector cells play an essential role in the pathophysiology of both graft-versus-host (GvH) and graft-versus-leukemia (GvL) reactions after transplantation. Therefore, we determined the kinetics of DC and T-cell chimerism establishment after allogeneic hematopoietic cell transplantation (AHCT) in a group of 144 patients, using fluorescence-activated cell sorting (FACS) or magnetic cell sorting (MACS) followed by FISH or STR-PCR analysis for chimerism evaluation. In all, three cell lines investigated (CD3+ T cells, CD11c+ DC1 and CD123+ DC2), we found a rapid and consistent establishment of complete donor chimerism (CDC) in over 70% of all patients during the first 6 weeks after AHCT. The rate of patients with CDC increased significantly over time within the first year after transplantation. A related donor (P=0.004) as well as an underlying lymphatic leukemia (P=0.03) were found to be significantly associated with development of MC in T cells. No significant correlation between DC or T cell chimerism and GvHD or relapse was detected. Our results thus demonstrate a fast and stable CDC in DC1, DC2 and T cells after AHCT that continuously increases over time in nearly all patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maris M, Woolfrey A, McSweeney PA, Sandmaier BM, Nash RA, Georges G et al. Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century. Front Biosci 2001; 6: G13–G16.
Frassoni F, Strada P, Sessarego M, Miceli S, Corvò R, Scarpati D et al. Mixed chimerism after allogeneic marrow transplantation for leukemia: correlation with dose of total body irradiation and graft-versus-host disease. Bone Marrow Transplant 1990; 5: 235–240.
van Leuween JEM, van Tol MJD, Joosten AM, Wijnen JT, Verweij PJM, Khan PM et al. Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood 1994; 83: 3059–3067.
Gyger M, Baron C, Forest L, Lussier P, Lagacé F, Bissonnette I et al. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs-host disease. Exp Hematol 1998; 26: 426–434.
Lion T . Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 2001; 15: 307–310.
Lawler SD, Baker MC, Harris H, Morgenstern GR . Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin. Br J Haematol 1984; 56: 431–443.
Durnam DM, Anders KR, Fisher L, O'Quigely J, Bryant EM, Thomas ED . Analysis of the origin of marrow cell in bone marrow transplant recipients using a Y-chromosome-specific in-situ hybridization assay. Blood 1989; 74: 2220–2226.
Fehse B, Chukhlovin A, Kuhlcke K, Marinetz O, Vorwig O, Renges H et al. Real-time quantitative y chromosome-specific pcr (qycs-pcr) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res 2001; 10: 419–425.
Thiede C, Bornhäuser M, Oelschlägel U, Brendel C, Leo R, Daxberger H et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001; 15: 293–302.
Lion T . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations. Leukemia 2001; 15: 292.
Thiele J, Wickenhauser C, Kvasnicka HM, Varus E, Schneider C, Muller H et al. Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation. Acta Haematol 2003; 109: 176–183.
Mattson J, Uzunel M, Remberger M, Ringden O . T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 2001; 71: 433–439.
Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, Leong W, Grumet FC, Blume KG et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99: 1442–1448.
Ferrara JLM, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.
Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004; 10: 510–517.
Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D et al. Donor APC are required for maximal GvHD but not for GVL. Nat Med 2004; 10: 987–992.
Arpinati M, Chirumbolo G, Urbini B, Perrone G, Rondelli D, Anasetti C . Role of plasmocytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transplant Immunol 2003; 11: 345–356.
Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CDL . Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1997; 29: 2769–2778.
Kohrgruber N, Halanek N, Gröger M, Winter D, Rappersberger K, Schmitt-Egenolf M et al. Survival, maturation, and function of CD11c− and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999; 163: 3250–3259.
Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183–1186.
Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C . Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484–2490.
Liu YJ, Blom B . Introduction: TH2-inducing DC2 for immunotherapy. Blood 2000; 95: 2482–2483.
Liu J, Anderson BE, Robert ME, McNiff JM, Emerson SG, Shlomchik WD et al. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model for the reversal of disease. Blood 2002; 98: 3367–3375.
Nachbaur D, Kirchner B, Eisendle K, Laetzner K, Haun M, Gastl G . Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003; 123: 119–126.
Clark FJ, Freeman L, Dzionek A, Schmitz J, McMullan D, Simpson P et al. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation 2003; 75: 221–225.
Chan GW, Gorgun G, Miller KB, Foss FM . Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170–176.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Thiede C, Florek M, Bornhäuser M, Ritter M, Mohr B, Brendel C et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055–1060.
Walsh PS, Metzger DA, Higuchi R . Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991; 10: 506–513.
Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J . GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258–261.
Galy A, Rudraraju S, Baynes R, Klein J . Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplant 2000; 25: 1249–1255.
Damiani D, Stocchi R, Masolini P, Michelutti A, Sperotto A, Geromin A et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplant 2002; 30: 261–266.
Baron F, Baker JE, Storb R, Gooley TA, Sandmaier BM, Maris MB et al. Kinetics of engraftment in patients with hematological malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004; 104: 2254–2262.
Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E et al. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation points to the donor CD8+ T cells count on day +14 as a predictor of acute graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 337–346.
Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004; 172: 7393–7398.
Hessel H, Mittermüller J, Zitzelsberger H, Weier HU, Bauchinger M . Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation. Histochem Cell Biol 1996; 106: 481–485.
Acknowledgements
This work is part of the doctoral thesis of Moritz Hamann.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boeck, S., Hamann, M., Pihusch, V. et al. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant 37, 57–64 (2006). https://doi.org/10.1038/sj.bmt.1705217
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705217
Keywords
This article is cited by
-
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin
Bone Marrow Transplantation (2022)
-
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT
Bone Marrow Transplantation (2008)
-
Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens
Leukemia (2007)
-
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
Leukemia (2006)